NDC 0781-3239-46 - Ciprofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3239
- Requested NDC
- 0781-3239-46
- Package NDCs from labels
- 0781-3239-46, 0781-3239-09
- Manufacturer
- Sandoz Inc
- Effective date
- 2015-03-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ciprofloxacin - Sandoz Inc | Sandoz Inc | 2015-03-10 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0781-3239-09 | 2020-05-07 | C162847 | 48780-1 | 9d75b9d0-c913-f424-e053-dadaa90a57ce | CIPROFLOXACIN INJECTION, USP For Intravenous Infusion |
| 0781-3239-09 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c913-f424-e053-dadaa90a57ce | CIPROFLOXACIN INJECTION, USP For Intravenous Infusion |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3239-09 | ML - Milliliter | 0781-3239 | 55d22f44-4b49-4232-93e8-0dbc9b32cbc8 | 1 | 2013-02-13 |
| 0781-3239-46 | ML - Milliliter | 0781-3239 | d50a1dd2-1999-475c-bb8b-c2f9da4f7cc0 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CIPROFLOXACIN | ACTIVE INGREDIENT | 5E8K9I0O4U | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| CIPROFLOXACIN | ACTIVE MOIETY | 5E8K9I0O4U | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b2b780d3-26ac-4e7c-a0f2-78991bee32a8 | 2025-05-07 | LX22YL083G | |
| Bestmade Natural Products BM182 Pellets | GRAPHITES, HEPAR SULF, MERC SOL, MURIATIC ACID | Bestmade Natural Products | 3242e013-2952-2b56-e063-6294a90a1693 | 2025-04-08 | Warnings | QTT17582CB |
| Aspartame/MSG Detox | CHELIDONIUM MAJUS, ARNICA MONTANA, PHYTOLACCA DECANDRA, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BISPHENOL A (BPA), DEXTROSE, MALTODEXTRIN, SUCRALOSE, ASPARTIC ACID, DIKETOPIPERAZINE, DOPAMINE HYDROCHLORIDE, FORMALINUM, FORMICUM ACIDUM, L-PHENYLALANINE, METHYL ALCOHOL, MONOSODIUM GLUTAMATE | Deseret Biologicals, Inc. | a1dc1bf3-db71-4550-a975-4f146fb94005 | 2025-03-11 | Warnings | LX22YL083G |
| Medicated Foaming Feminine | LACTIC ACID, BORIC ACID, CHLORHEXIDINE GLUCONATE, CNIDIUM MONNIERI FRUIT, LEVOMENOL | Rida LLC | 02b3d683-05b0-4075-bbf9-e6d97c61765c | 2025-03-06 | Warnings | 33X04XA5AT |
| FEELSHION Glycolic Acid Exfoliating Face Pads | PROPYLENE GLYCOL,ARGININE,LACTIC ACID,SALICYLIC ACID,GLYCOLIC ACID | Beijing JUNGE Technology Co., Ltd. | 2e79678c-1ce4-25cf-e063-6394a90a133c | 2025-02-19 | Warnings | 33X04XA5AT |
| Bestmade Natural Products BM62 | AMMONIUM BENZOICUM, AURUM MUR, CALC ARS, CARDUUS MAR, CROTALUS HORRIDUS, MURIATIC ACID, NUX VOM, PHOSPHORUS, VIPERA | Bestmade Natural Products | 2ce99cb7-fe9e-5da2-e063-6294a90afc4e | 2025-01-30 | Warnings | QTT17582CB |
| Glucose and Sodium Chloride | DEXTROSE ANHYDROUS AND SODIUM CHLORIDE | Baxter Healthcare Corporation | 1ba918d0-13d0-48bc-8742-658fc0eb47b6 | 2025-01-24 | LX22YL083G | |
| Anticoagulant Citrate Dextrose A ACD-A | ANTICOAGULANT CITRATE DEXTROSE A ACD-A | Arteriocyte Medical Systems, Inc. | b850deac-161f-4bb0-ac7f-bceac2a230c0 | 2025-01-23 | LX22YL083G | |
| ACD A | DEXTROSE MONOHYDRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | Terumo BCT Ltd | 570770de-9b48-4fc1-a1ee-06002ca9504f | 2025-01-22 | LX22YL083G | |
| Anticoagulant Citrate Dextrose (ACD-A) | DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE | Terumo BCT, Ltd | 0130d7c8-d067-4528-beb7-166559c33be9 | 2025-01-21 | Warnings, Adverse reactions | LX22YL083G |
| D-99 | ATROPA BELLADONNA, NITROGLYCERIN, LACTIC ACID, UNSPECIFIED FORM, SCROPHULARIA NODOSA, ALOE, RADIUM BROMIDE, POTASSIUM IODIDE, SUS SCROFA BONE MARROW, ZINC, AND CITRIC ACID MONOHYDRATE | DNA Labs, Inc. | dd9c0226-35ea-445a-a570-1ec35551f68d | 2025-01-13 | Warnings | 33X04XA5AT |
| D-114 | ALUMINUM METALLICUM, AILANTHUS, BAPTISIA TINCTORIA, FRAGARIA VESCA, YOSCYAMUS NIGER, MURIATICUM ACID | DNA Labs | f6f7d369-64ef-0ed9-e053-6294a90a40fa | 2025-01-13 | Warnings | QTT17582CB |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | c1d0f42e-3494-4217-8f86-e9f34d930e82 | 2025-01-07 | Warnings, Adverse reactions | LX22YL083G |
| Stress Away Anxiety Relief | ACONITUM NAP, ALFALFA, AVENA, CHAMOMILLA, GELSEMIUM, HUMULUS IUPULUS, IGNATIA, KALI ARS, KALI PHOS, MURIATICUM AC, NAT PHOS, PASSIFLORA, PHOSPHORUS, STAPHYSAGRIA, STRAMONIUM | Silver Star Brands | 05e04129-e7c1-4e11-e063-6394a90a09ca | 2025-01-01 | Warnings | QTT17582CB |
| Stress Away Anxiety Relief | ACONITUM NAP, ALFALFA, AVENA, CHAMOMILLA, GELSEMIUM, HUMULUS LUPULUS, IGNATIA, KALI ARS, KALI PHOS, MURIATICUM AC, NAT PHOS, PASSIFLORA, PHOS, STAPHYSAG, STRAMONIUM | Silver Star Brands | 9d75666e-3214-2bab-e053-2a95a90af719 | 2024-12-03 | Warnings | QTT17582CB |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | d3f90d2f-4536-4d32-800b-7a798f8a35db | 2024-11-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 68cc9c41-ed24-4f76-8efb-2936ae3ddd8d | 2024-10-29 | Warnings, Adverse reactions | LX22YL083G |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | LX22YL083G |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | LX22YL083G |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.